Document is current
Any future updates will be listed below
-
Authors
Li, Bingqi
Zeng, Xiaofei
Jiang, Jing
Zhou, Qian
Tong, Li
Liang, Xi
Xin, Jiaojiao
Chen, Xi
Wu, Xiao
Kong, Yuheng
Ma, Shiwen
Luo, Jinjin
Qiang, Wei
Zhu, Bing
Luo, Xinhua
Li, Jun https://orcid.org/0000-0002-7236-8088
Shi, Dongyan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82370634)
National Natural Science Foundation of China (32330057)
Key Technologies Research and Development Program (2022YFA1104100)
Key Technologies Research and Development Program (2022YFA1104600)
Key Research and Development Program of Zhejiang Province (2025C02130)
the National special support program for high-level personnel recruitment (Ten-thousand Talents Program)
- License Information
-
More Information
Article History
Received: 21 April 2025
Accepted: 18 July 2025
First Online: 10 August 2025
Declarations
:
: The study was approved by the ethics review committee of the First Affiliated Hospital of Zhejiang University School of Medicine (Title of the approved project: Research on and application of novel technologies, strategies and equipment for the diagnosis and treatment of severe hepatitis B (liver failure); ethical reference number: 2017–51; data of approval: 14th Feb, 2017). The animal experiments were approved by the Animal Experimental Ethical Inspection of the First Affiliated Hospital, Zhejiang University School of Medicine (Title of the approved project: Research on the mechanism of regenerative repair and new treatment strategy of liver failure; ethical reference number: 2024–1626; data of approval: 26th Sep, 2024).
: The authors declare no conflict of interests.
